Group cognitive behavioural therapy increases complete remission of obsessive-compulsive disorder symptoms compared with sertraline, but not response
Koen Schruers
Abstract
Koen Schruers
Abstract
Sousa MB, Isolan LR, Oliveira RR, et al . A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. J Clin Psychiatry 2006;67:1133–9.[OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q What is the efficacy of group cognitive behavioural therapy compared with sertraline for reducing obsessive-compulsive disorder symptoms in adults? ### ![Graphic][5] Design: Randomised controlled trial. ### ![Graphic][6] Allocation: Concealed. ### ![Graphic][7] Blinding: Single blind (assessors blinded). ### ![Graphic][8] Follow up period: Twelve weeks (treatment period only). ### ![Graphic][9] Setting: Outpatient setting in Brazil; March 2002 to December 2003. ### ![Graphic][10] Patients: Fifty six adults (mean 38.5 years) with diagnosed with DSM-IV obsessive-compulsive disorder (OCD; Mini-International Neuropsychiatric Interview – Brazilian version), and a Yale-Brown Obsessive Compulsive Scale (YBOCS) score of ⩾16. Main exclusion criteria: moderate to severe major depression, Beck Depression Inventory score >16, bipolar disorder, severe personality disorder, psychotic disorder, substance related disorder in the previous six months, Tourette’s syndrome, or organic brain disease. ### ![Graphic][11] Intervention: Group cognitive behavioural therapy (CBT; weekly two-hour group session) or sertraline (50 mg/day in the … [1]: {openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bclinical%2Bpsychiatry%26rft.stitle%253DJ%2BClin%2BPsychiatry%26rft.aulast%253DSousa%26rft.auinit1%253DM.%2BB.%26rft.volume%253D67%26rft.issue%253D7%26rft.spage%253D1133%26rft.epage%253D1139%26rft.atitle%253DA%2Brandomized%2Bclinical%2Btrial%2Bof%2Bcognitive-behavioral%2Bgroup%2Btherapy%2Band%2Bsertraline%2Bin%2Bthe%2Btreatment%2Bof%2Bobsessive-compulsive%2Bdisorder.%26rft_id%253Dinfo%253Adoi%252F10.4088%252FJCP.v67n0717%26rft_id%253Dinfo%253Apmid%252F16889458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.4088/JCP.v67n0717&link_type=DOI [3]: /lookup/external-ref?access_num=16889458&link_type=MED&atom=%2Febmental%2F10%2F1%2F25.atom [4]: /lookup/external-ref?access_num=000239548300017&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif [7]: /embed/inline-graphic-3.gif [8]: /embed/inline-graphic-4.gif [9]: /embed/inline-graphic-5.gif [10]: /embed/inline-graphic-6.gif [11]: /embed/inline-graphic-7.gif
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sousa MB, Isolan LR, Oliveira RR, et al . A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. J Clin Psychiatry 2006;67:1133–9.[OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q What is the efficacy of group cognitive behavioural therapy compared with sertraline for reducing obsessive-compulsive disorder symptoms in adults? ### ![Graphic][5] Design: Randomised controlled trial. ### ![Graphic][6] Allocation: Concealed. ### ![Graphic][7] Blinding: Single blind (assessors blinded). ### ![Graphic][8] Follow up period: Twelve weeks (treatment period only). ### ![Graphic][9] Setting: Outpatient setting in Brazil; March 2002 to December 2003. ### ![Graphic][10] Patients: Fifty six adults (mean 38.5 years) with diagnosed with DSM-IV obsessive-compulsive disorder (OCD; Mini-International Neuropsychiatric Interview – Brazilian version), and a Yale-Brown Obsessive Compulsive Scale (YBOCS) score of ⩾16. Main exclusion criteria: moderate to severe major depression, Beck Depression Inventory score >16, bipolar disorder, severe personality disorder, psychotic disorder, substance related disorder in the previous six months, Tourette’s syndrome, or organic brain disease. ### ![Graphic][11] Intervention: Group cognitive behavioural therapy (CBT; weekly two-hour group session) or sertraline (50 mg/day in the … [1]: {openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2Bclinical%2Bpsychiatry%26rft.stitle%253DJ%2BClin%2BPsychiatry%26rft.aulast%253DSousa%26rft.auinit1%253DM.%2BB.%26rft.volume%253D67%26rft.issue%253D7%26rft.spage%253D1133%26rft.epage%253D1139%26rft.atitle%253DA%2Brandomized%2Bclinical%2Btrial%2Bof%2Bcognitive-behavioral%2Bgroup%2Btherapy%2Band%2Bsertraline%2Bin%2Bthe%2Btreatment%2Bof%2Bobsessive-compulsive%2Bdisorder.%26rft_id%253Dinfo%253Adoi%252F10.4088%252FJCP.v67n0717%26rft_id%253Dinfo%253Apmid%252F16889458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.4088/JCP.v67n0717&link_type=DOI [3]: /lookup/external-ref?access_num=16889458&link_type=MED&atom=%2Febmental%2F10%2F1%2F25.atom [4]: /lookup/external-ref?access_num=000239548300017&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif [7]: /embed/inline-graphic-3.gif [8]: /embed/inline-graphic-4.gif [9]: /embed/inline-graphic-5.gif [10]: /embed/inline-graphic-6.gif [11]: /embed/inline-graphic-7.gif
Key concepts: Sertraline, Obsessive compulsive, Complete remission, Psychotherapist, Cognition, Exposure and response prevention, Medicine, Psychology